From Innovation to Impact: Introducing Project Alzheimer’s Value Europe
This report summarizes key insights from the work of the Pathways for the Introduction of Alzheimer’s disease Treatments (PIAdT) Working Group and introduces opportunities for the new Project Alzheimer’s Value Europe (PAVE) initiative to support timely access to forthcoming Alzheimer’s disease innovations through improved models for value assessment and funding.
How Alzheimer’s Disease Registries Can Facilitate Holistic Value Assessments
This paper highlights PAVE’s research findings around the present use of - and future opportunities for - European Alzheimer’s disease registries to support holistic value assessment decisions of emerging treatments and therapies
2022 Commentary: “Overcoming the Barriers to Value Assessment of New Innovations in Alzheimer’s Disease”
This report reviews assessment methods currently employed by European HTA bodies to identify challenges and opportunities related to holistic value assessment of AD therapies.
